Skip to main content
CRS 2026 Annual Meeting & Exposition Main banner

Nanomedicine and Nanoscale Delivery (Focus Group – NND)

Polymer-based nanogel tailored for in situ and parenteral administration

Jarak Ivana – Researcher, FFUC; Jorge Coelho – Full Professor, FCTUC; Carla Varela – Researcher, FCTUC; Elisiário Silva – Assistant Professor, FFUC; Fernanda Roleira – Assistant Professor, FFUC; Marília Dourado – Associate Professor, FMUC; Ana Figueiras – Assistant Professor, FFUC
Introduction:

Oral squamous cell carcinoma (OSCC) arises from the oral mucosa and severely affects quality of life by impairing appearance, speech, swallowing, and taste. The oral cancer treatment market is projected to reach nearly USD 5 billion by 2033. OSCC represents ca. 90% of oral cancers, with most cases diagnosed late, leading to high metastasis, recurrence, and a poor five-year survival rate. This invention proposes a hydrogel that enables treatment of both local and metastatic OSCC.

Learning Objectives:

  • Understand the design and synthesis of polymer-based hydrogels for drug delivery.
  • Define polymer-based hydrogels strategies for genetic material delivery in oral cancer therapy.
  • Evaluate the translational potential of hydrogels in oncological treatment.